Cargando…

A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals

Background: Seventy-five percent of fecal immunochemical test (FIT)-positive individuals are false positives and undergo unnecessary colonoscopies. Here, we established a stool DNA (sDNA) test that uses the Single Allele Base Extension Reaction (SABER) MassARRAY platform to improve the accuracy of F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Pi-Yueh, Chen, Chia-Chun, Chiang, Jy-Ming, Chang, Shih-Cheng, Wang, Mei-Chia, Chen, Jinn-Shiun, Tsai, Wen-Sy, You, Jeng Fu, Lu, Jang-Jih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468462/ https://www.ncbi.nlm.nih.gov/pubmed/30934598 http://dx.doi.org/10.3390/cancers11030423

Ejemplares similares

MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection
por: Chang, Pi-Yueh, et al.
Publicado: (2016)

Pathogenic Germline Mutations of DNA Repair Pathway Components in Early-Onset Sporadic Colorectal Polyp and Cancer Patients
por: Chang, Pi-Yueh, et al.
Publicado: (2020)

Screening of single nucleotide polymorphisms within HLA region related to hematopoietic stem cell transplantation using MassARRAY technology
por: Tsai, Shu-Hui, et al.
Publicado: (2023)

Analysis of PTEN Methylation Patterns in Soft Tissue Sarcomas by MassARRAY Spectrometry
por: Yin, Liang, et al.
Publicado: (2013)

MassArray analysis of genomic susceptibility variants in ovarian cancer
por: Verma, Sonali, et al.
Publicado: (2020)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
por: Xu, Hongli, et al.
Publicado: (2022)

NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing
por: Chang, Pi-Yueh, et al.
Publicado: (2016)

Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer
por: Chang, Pi-Yueh, et al.
Publicado: (2017)

Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms
por: Chiang, Tsung-Hsien, et al.
Publicado: (2015)

Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)
por: Heigh, Russell I., et al.
Publicado: (2014)

Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis
por: Mo, Shaobo, et al.
Publicado: (2021)

Performance of MassARRAY system for the detection of SARS-CoV-2 compared to real-time PCR
por: AlMutawa, Fatimah, et al.
Publicado: (2023)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology
por: Ibarrola-Villava, Maider, et al.
Publicado: (2016)

MassARRAY-based single nucleotide polymorphism analysis in breast cancer of north Indian population
por: Bakshi, Divya, et al.
Publicado: (2020)

Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform
por: Tian, Hong-Xia, et al.
Publicado: (2016)

DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model
por: Baxter, Nielson T., et al.
Publicado: (2016)

Concurrent colonic mucosa-associated lymphoid tissue lymphoma and adenoma diagnosed after a positive fecal occult blood test: a case report
por: Lin, Pei-Chiang, et al.
Publicado: (2016)

Evaluation of 41 single nucleotide polymorphisms in canine diffuse large B-cell lymphomas using MassARRAY
por: Sirivisoot, Sirintra, et al.
Publicado: (2022)

Correction to: Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial
por: Shin, Hye Young, et al.
Publicado: (2016)

Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology
por: Clendenen, Tess V., et al.
Publicado: (2015)

Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study
por: Shin, Hye Young, et al.
Publicado: (2018)

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
por: Zeng, Tao, et al.
Publicado: (2023)

Whole-Genome Sequencing and iPLEX MassARRAY Genotyping Map an EMS-Induced Mutation Affecting Cell Competition in Drosophila melanogaster
por: Lee, Chang-Hyun, et al.
Publicado: (2016)

Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program
por: Chiu, Han-Mo, et al.
Publicado: (2015)

Screening of genetic alterations related to non-syndromic hearing loss using MassARRAY iPLEX® technology
por: Svidnicki, Maria Carolina CCosta CMelo, et al.
Publicado: (2015)

MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India
por: Shah, Ruchi, et al.
Publicado: (2020)

Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians
por: Bhat, Gh. Rasool, et al.
Publicado: (2021)

Simultaneous detection of omicron and other SARS-CoV-2 variants by multiplex PCR MassARRAY technology
por: Wacharapluesadee, Supaporn, et al.
Publicado: (2023)

Simultaneous Detection of Omicron and Other SARS-CoV-2 Variants by Multiplex PCR MassARRAY Technology
por: Wacharapluesadee, Supaporn, et al.
Publicado: (2023)

Positive fecal immunochemical test results are associated with non-colorectal cancer mortality
por: Jung, Yoon Suk, et al.
Publicado: (2022)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis
por: Chang, Ji Young, et al.
Publicado: (2018)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs
por: D’Aquila, Patrizia, et al.
Publicado: (2021)

Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy
por: Chiang, Jy Ming, et al.
Publicado: (2014)

Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
por: Chen, Justin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_na5grfm0jcu6peopm299b2fqnd